Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaofei Chang

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Updates in Surgery|July 11, 2023
Bi's purse-string suture: an effective method for presacral venous bleedingShaofei Chang, Yaohua Liu, Jien Guo, et al.
Journal of Surgical Oncology|May 27, 2023
Prognostic nutritional score based on pretreatment lymphocyte, platelet, and prealbumin predicts prognosis in patients with pancreatic cancerYuexiang Liang, Hanhan Guo, Quan Man, et al.
American Journal of Cancer Research|June 9, 2023
Presence of tumor deposits is an indicator of poor prognosis in patients with pancreatic ductal adenocarcinomaYuexiang Liang, Shaofei Chang, Hanhan Guo, et al.
Medicine|March 8, 2024
Nomogram model for predicting early recurrence for resectable pancreatic cancer: A multicenter studyQuan Man, Huifang Pang, Yuexiang Liang, et al.
World Journal of Surgical Oncology|October 29, 2024
Fibrinogen to pre-albumin ratio is an independent prognostic index for patients with pancreatic ductal adenocarcinoma after radical resectionShaofei Chang, Yiping Zou, Jing Huang, et al.
Cancer Reports (Hoboken, N.J.)|October 12, 2023
Biological risk based on preoperative serum CA19-9 and histological grade predicts prognosis and improves accuracy of classification in patients with pancreatic ductal adenocarcinomaShaofei Chang, Yaohua Liu, Yuexiang Liang, et al.
Frontiers in Oncology|November 1, 2023
Comparison of adjuvant nab-paclitaxel plus gemcitabine, S-1 and gemcitabine chemotherapy for resectable pancreatic cancer: a real-world studyHaorui Li, Yu Guo, Xugang Sun, et al.
Iscience|September 4, 2023
A new staging system for postoperative prognostication in pancreatic ductal adenocarcinomaYuexiang Liang, Jingli Cui, Fanghui Ding, et al.
Cancer Biology & Medicine|January 3, 2024
Prognostic significance of grade of malignancy based on histopathological differentiation and Ki-67 in pancreatic ductal adenocarcinomaYuexiang Liang, Guannan Sheng, Yu Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2023
Nuclear GRP78 Promotes Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Ductal AdenocarcinomaTiansuo Zhao, Tingting Jiang, Xiaojia Li, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Updates in Surgery|July 11, 2023
Bi's purse-string suture: an effective method for presacral venous bleedingShaofei Chang, Yaohua Liu, Jien Guo, et al.
Journal of Surgical Oncology|May 27, 2023
Prognostic nutritional score based on pretreatment lymphocyte, platelet, and prealbumin predicts prognosis in patients with pancreatic cancerYuexiang Liang, Hanhan Guo, Quan Man, et al.
American Journal of Cancer Research|June 9, 2023
Presence of tumor deposits is an indicator of poor prognosis in patients with pancreatic ductal adenocarcinomaYuexiang Liang, Shaofei Chang, Hanhan Guo, et al.
Medicine|March 8, 2024
Nomogram model for predicting early recurrence for resectable pancreatic cancer: A multicenter studyQuan Man, Huifang Pang, Yuexiang Liang, et al.
World Journal of Surgical Oncology|October 29, 2024
Fibrinogen to pre-albumin ratio is an independent prognostic index for patients with pancreatic ductal adenocarcinoma after radical resectionShaofei Chang, Yiping Zou, Jing Huang, et al.
Cancer Reports (Hoboken, N.J.)|October 12, 2023
Biological risk based on preoperative serum CA19-9 and histological grade predicts prognosis and improves accuracy of classification in patients with pancreatic ductal adenocarcinomaShaofei Chang, Yaohua Liu, Yuexiang Liang, et al.
Frontiers in Oncology|November 1, 2023
Comparison of adjuvant nab-paclitaxel plus gemcitabine, S-1 and gemcitabine chemotherapy for resectable pancreatic cancer: a real-world studyHaorui Li, Yu Guo, Xugang Sun, et al.
Iscience|September 4, 2023
A new staging system for postoperative prognostication in pancreatic ductal adenocarcinomaYuexiang Liang, Jingli Cui, Fanghui Ding, et al.
Cancer Biology & Medicine|January 3, 2024
Prognostic significance of grade of malignancy based on histopathological differentiation and Ki-67 in pancreatic ductal adenocarcinomaYuexiang Liang, Guannan Sheng, Yu Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2023
Nuclear GRP78 Promotes Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Ductal AdenocarcinomaTiansuo Zhao, Tingting Jiang, Xiaojia Li, et al.
Pageof 2